An interventional study of Laser uretherotomy and Laser uretherotomy with triamcinolone in Urethral Stricture, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to male participants aged 26 Years to 69 Years. Per ClinicalTrials.gov, last updated 2021-10-15.
Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment
the purpose is to evaluate the outcome of visual internal uretherotomy with Holmium laser along with intralesional steroid injection.
In this study, the investigator evaluates the efficacy of Holmium laser in combination with intra lesional steroid injection in the treatment of bulbar urethral strictures
68 studies on the registry are indexed under Urethral Stricture; 23 are open to participants now.
This study's enrollment of 124 is above the median of 60 across 53 interventional studies indexed under Urethral Stricture.
Browse Urethral Stricture studies →Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Using Holmium laser uretherotomy only in the treatment of bulbar uretheral stricture
Procedure: Laser uretherotomy
Using holmium laser uretherotomy with injection of 80 mg of triamcinolone (diluted with normal saline to 10 ml) in the treatment of bulbar uretheral stricture
Procedure: Laser uretherotomy with triamcinolone
Holmium YAG Laser with pulse energy from 1-2 Joule, frequency from 10-15 Hertz and total power from 3.0 to 30.0 Watt were set up, respectively, based on the extent of the lesions. Scar tissue was incised at the position of 12-o'clock under the guidance of guidewire or ureteric catheter till fresh mucosa appeared.
After laser urethrotomy, 80 mg of triamcinolone (diluted with normal saline to 10 ml) will be injected by using an injection needle (5 F size and 23 G needle size) at 10 sites, 1 ml each, along the site of urethrotomy and circumferentially.
the maximum flow rate (Qmax) is >15 ml/s at 3 and 6 months after procedure
The procedure will be accepted as successful when the maximum flow rate (Qmax) is \>15 ml/s.
Time frame: 3 and 6 months
This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ain Shams University